SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (280)3/30/1999 12:09:00 PM
From: Biomaven  Read Replies (1) | Respond to of 3557
 
Well AMGN put on a couple of billion in market cap when they first licensed the leptin stuff, and this definitely seems a better shot than leptin ...

Might be time to re-read the PNAS article:

pnas.org

Here's a list of some obesity drugs under development:

vais.net

And here's some stuff on Axokine for retinal degeneration:

chong.demon.co.uk

Peter